HomeAuthor

Jim Edson

J&W Board of Directors

Paragon 28 Announces Addition of B. Kristine Johnson and Kristina Wright to its Board of Directors December 01, 2021 07:00 AM Eastern Standard Time ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today the appointment of B. Kristine Johnson and...

P28 Training

Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced today that the U.S. Food and Drug Administration (FDA) has given 501(k) marketing clearance to its Circular External Fixation System. The Circular External Fixation System, expected to commercially launch in early 2022, will...

Paragon 28 (NYSE: FNA) rings The Opening Bell®

The New York Stock Exchange welcomes Paragon 28 (NYSE: FNA), today, Friday, October 15, 2021, in celebration of its Initial Public Offering. To honor the occasion, Albert DaCosta, President and CEO, and his mother, Amy DaCosta, joined by John Tuttle, NYSE Vice Chairman and Chief Commercial Officer, ring The Opening Bell®.

Photo Credit: NYSE

ENGLEWOOD, Colo., Oct. 15, 2021 /PRNewswire/ — Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the pricing of its initial public offering of 7,812,500 shares of its common stock at a public offering price of $16.00 per share, for total gross proceeds of $125.0 million, before deducting underwriting...

Paragon 28 Logo
14445 Grasslands Dr. Englewood, CO 80112

Follow us:

CALL US

The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.

© 2024 Paragon 28, Inc.

Privacy Policy